Catic-Djordjevic, Aleksandra published the artcileAssessment of pharmacokinetic mycophenolic acid clearance models using Monte Carlo numerical analysis, Recommanded Product: Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, the main research area is mycophenolic acid pharmacokinetics Monte Carlo simulation; Monte Carlo simulation; Mycophenolic acid; clearance; population pharmacokinetic analysis; renal transplant patients.
Previously, we performed population pharmacokinetic anal. and indicated age, mycophenolate mofetil (MMF)/mycophenolic acid (MPA) daily dose, and presence of nifedipine in patient therapy as significant predictors of MPA apparent clearance (CL/F) variability. This study aimed to determine the reliability of previously published population pharmacokinetic models derived from similar studies. Furthermore, this study investigated correspondence between chosen population models from the literature. By means of the Monte Carlo simulation method, pharmacokinetic models from different studies are simulated and analyzed in the range of standard deviations of measured system parameters as well as the range of observed model parameters taken from the comparison studies. The 1000 numerical simulations were performed for every analyzed model in order to calculate the most possible MPA CL/F values according to the expected values from the performed experiment Fitting our results with other models showed how the presence of nifedipine makes difference in MPA CL/F values. By testing the data from selected studies into our model, a similar range of expected CL/F values was obtained, which may confirm the validity of our model. The results of our population pharmacokinetic study are partially applicable in models by other researchers.
Xenobiotica published new progress about Albumins Role: BSU (Biological Study, Unclassified), BIOL (Biological Study). 21829-25-4 belongs to class pyridine-derivatives, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, Recommanded Product: Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.